Withdrawal from several major classes of drugs, both recreational and prescribed, can trigger psychotic symptoms including hallucinations, delusions, and paranoia. This is not a rare curiosity confined to extreme cases of addiction. A large survey of people with substance use disorders found that roughly half of those who abused cocaine or cannabis reported psychotic symptoms during use or withdrawal, and the rate was even higher among those dependent on amphetamines or opioids.1Comprehensive Psychiatry. Prevalence of psychotic symptoms in substance users: a comparison across substances The phenomenon also extends to medications taken exactly as prescribed, including benzodiazepines, antipsychotics, and dopamine agonists. How and why it happens depends heavily on the substance involved.
Alcohol Withdrawal and Psychosis
Alcohol is the substance most commonly associated with withdrawal psychosis, and its timeline is well mapped. After a person with heavy, chronic alcohol use stops drinking, withdrawal unfolds in stages. Minor symptoms like anxiety, tremor, and insomnia can appear within six hours. Between roughly eight and twelve hours, alcohol hallucinosis can emerge, bringing vivid auditory, visual, or tactile hallucinations, sometimes accompanied by paranoia and delusions. Seizures can follow between twelve and twenty-four hours, and the most severe stage, known as delirium tremens, typically arrives between twenty-four and seventy-two hours after the last drink. Delirium tremens involves confusion, altered consciousness, severe autonomic instability, and persistent hallucinations.2PubMed Central. Simulation Alcohol Withdrawal with Delirium Tremens
The mechanism behind alcohol withdrawal psychosis comes down to how the brain adapts to chronic alcohol exposure. Alcohol enhances the brain’s main inhibitory system while suppressing its main excitatory system. Over time, the brain compensates by dialing down the inhibitory side and ramping up the excitatory side to maintain balance. When alcohol is suddenly removed, that compensatory state is exposed: excitatory activity runs unopposed, leading to a state of neural overdrive that manifests as seizures, hallucinations, and delirium.3Journal of Clinical and Experimental Hepatology. Delirium Tremens: Assessment and Management
There is an important distinction between delirium tremens and a separate condition called alcoholic hallucinosis. Delirium tremens involves a clouded, confused state of consciousness along with hallucinations. Alcoholic hallucinosis, by contrast, features hallucinations that arise in clear consciousness: the person is oriented and aware of their surroundings but hears voices or sees things that are not there. The voices are often vivid and accusatory. In some cases, alcoholic hallucinosis can become chronic and closely resemble schizophrenia, which can make diagnosis tricky.4PubMed Central. Alcoholic hallucinosis This matters practically because the two conditions have different treatment approaches and different prognoses.
Benzodiazepine Withdrawal
Benzodiazepines work on the same inhibitory brain system that alcohol affects, so their withdrawal syndrome shares a family resemblance with alcohol withdrawal, including the potential for psychosis. The most severe benzodiazepine withdrawal symptoms include hallucinations, delusions, delirium, depersonalization, panic attacks, and seizures. Psychosis and suicidality are among the most serious possible adverse events during withdrawal.5Brain Communications. Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development These reactions have been reported with high-dose use, but early research noted that even people taking benzodiazepines at prescribed therapeutic doses for several years could develop withdrawal psychosis after abrupt cessation, sometimes appearing as late as two weeks into the withdrawal phase.6PubMed. The benzodiazepine withdrawal syndrome
Case reports have documented particularly severe psychotic episodes after withdrawal from short-acting benzodiazepines like alprazolam, where patients developed acute delirium with dramatic behavioral disturbances.7Journal of Clinical Psychopharmacology. Severe Alprazolam Withdrawal With Delirium and Psychosis: A Case Report and Literature Review The underlying mechanism is similar in concept to alcohol withdrawal. With prolonged benzodiazepine use, the receptor that benzodiazepines bind to becomes less responsive, and one theory holds that the link between the drug’s binding site and the brain’s own inhibitory machinery becomes “uncoupled” over time, requiring more drug to maintain the same effect. When the drug is removed, the brain’s excitatory systems, which have been upregulated to compensate, go into overdrive.8Journal of Stem Cell Research. Restoration of GABAA Receptor Function after Benzodiazepine Use: A Meta-Analysis
Because benzodiazepines are so widely prescribed for anxiety, insomnia, and seizure disorders, the withdrawal risk is a genuine public health concern. Many people who take them long-term are not aware that stopping cold turkey can be medically dangerous, not just uncomfortable. The short-acting varieties tend to produce more abrupt and intense withdrawal, while longer-acting ones have a more gradual offset, which is why clinicians often switch patients from a short-acting to a long-acting benzodiazepine as part of a tapering strategy.
Antipsychotic Withdrawal and Supersensitivity Psychosis
Here is a counterintuitive problem: the very medications used to treat psychosis can cause it when stopped. Long-term use of antipsychotic drugs leads the brain to increase both the number and sensitivity of the dopamine receptors that the drugs have been blocking. When the drug is removed, especially abruptly, those upregulated and supersensitive receptors are suddenly flooded with dopamine that they are now primed to overrespond to. The result can be a rebound psychosis that looks like a relapse of the original illness but is actually a pharmacological withdrawal effect.9PubMed Central. Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review This phenomenon is known as supersensitivity psychosis, and it has been linked to both rebound psychotic symptoms and movement disorders like tardive dyskinesia.10PubMed. Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Distinguishing supersensitivity psychosis from a genuine relapse of the underlying condition like schizophrenia is one of the hardest problems in clinical psychiatry. If someone stops their antipsychotic and develops psychotic symptoms within days or weeks, the immediate assumption is usually that the original illness has returned. But in some cases, the psychosis is a withdrawal artifact that would resolve if managed properly, rather than proof that the person needs to stay on the medication indefinitely. Faster dose reductions tend to cause greater disruption to the brain’s adapted state, which is why gradual tapering is considered protective: slower reductions give the brain time to readjust its receptor sensitivity downward.11PubMed Central. Gradually tapering off antipsychotics: lessons for practice from case studies and neurobiological principles
In a qualitative study within a clinical trial, over half of patients attempting to reduce or discontinue antipsychotics experienced deteriorations in mental health, including psychotic symptoms and what they described as intolerable levels of emotional intensity. Nine participants in the study had a full psychotic relapse.12eClinicalMedicine. Experiences of reduction and discontinuation of antipsychotics: a qualitative investigation within the RADAR trial A larger survey of 585 people who attempted to withdraw from antipsychotics found that about 18% reported psychosis as a withdrawal effect, alongside other common symptoms like insomnia, nervousness, and extreme emotions.13Addictive Behaviors Reports. The experiences of 585 people when they tried to withdraw from antipsychotic drugs Interestingly, about a quarter of respondents in that survey reported positive outcomes from withdrawal, including more energy and clearer thinking, which underscores how individual responses to stopping these medications can vary dramatically.
Cannabis Withdrawal Psychosis
Cannabis withdrawal psychosis has been more controversial than alcohol or benzodiazepine withdrawal psychosis, partly because cannabis withdrawal itself was only formally recognized as a clinical syndrome relatively recently. But the evidence has been building. A systematic review identified 44 individuals across 21 studies in whom stopping cannabis preceded the development of acute psychosis. A supplementary health record analysis added another 68 cases. Almost all of these individuals were daily users who had stopped abruptly.14PubMed Central. Psychosis associated with cannabis withdrawal: systematic review and case series
One finding from that review stands out. Among people who experienced psychosis during cannabis withdrawal, those who resumed using cannabis after the acute episode had a dramatically higher risk of subsequent psychotic relapse compared to those who stayed abstinent, with odds roughly fourteen times higher.14PubMed Central. Psychosis associated with cannabis withdrawal: systematic review and case series That statistic complicates a simple “cannabis caused the psychosis” narrative. It suggests these individuals may have an underlying vulnerability to psychosis that cannabis both masks and exacerbates in complex ways.
Case reports have reinforced that abrupt cessation of heavy, long-term cannabis use can induce or worsen psychotic symptoms in vulnerable people.15Psychiatry Research Case Reports. Onset and exacerbation of first episode psychosis associated with cannabis withdrawal: A case series The word “vulnerable” is doing real work in that sentence. Not everyone who quits heavy cannabis use will develop psychosis. The people who do tend to have risk factors like a family history of psychotic illness, very heavy daily use, and abrupt rather than gradual cessation. This is an area where the science is still developing, and clinicians are working to figure out who is most at risk.
Dopamine Agonist Withdrawal
A different flavor of withdrawal psychosis occurs with dopamine agonists, medications prescribed for Parkinson’s disease and restless legs syndrome. These drugs directly stimulate dopamine receptors, and stopping them can produce a withdrawal syndrome that includes anxiety, panic attacks, depression, pain, and in some cases psychotic features. A retrospective study found that the risk of developing this withdrawal syndrome was strongly linked to the dose at the time of withdrawal, the presence of impulse control disorders during treatment, and a history of deep brain stimulation surgery. When all three risk factors were present, the probability of developing the withdrawal syndrome was about 92%. With no risk factors present, it dropped to around 3%.16PubMed Central. Dopamine agonist withdrawal syndrome associated factors: A retrospective chart review
The dopamine agonist withdrawal syndrome is distinct from the withdrawal effects seen with antipsychotics, even though both involve dopamine. With antipsychotics, the brain upregulates dopamine receptors in response to blockade; with dopamine agonists, the brain downregulates them in response to excessive stimulation. In both cases, removing the drug abruptly unmasks an adapted state, but the underlying receptor changes go in opposite directions. The clinical picture differs too: dopamine agonist withdrawal tends to feature more severe depression and apathy alongside any psychotic symptoms, while antipsychotic withdrawal tends to produce more florid hallucinations and delusions.
The Common Thread Across Substances
Despite the variety of drugs that can produce withdrawal psychosis, the basic story is remarkably consistent. The brain adapts to the chronic presence of a substance by adjusting its receptor systems in the opposite direction to the drug’s effect. Drugs that enhance inhibition cause the brain to become more excitable; drugs that block certain receptors cause the brain to make more of those receptors or make them more sensitive. When the drug is removed, the adapted state is suddenly unmasked, and the brain overshoots in the opposite direction from the drug’s effect. In the case of psychosis, this overshoot involves excessive excitatory signaling, runaway dopamine activity, or both.
The speed of drug removal matters across virtually all of these substances. Abrupt cessation is far more likely to produce psychotic symptoms than gradual tapering, because the brain’s compensatory changes need time to reverse. This is why a systematic review of psychiatric drug withdrawal strategies found that gradual dose reduction was the most commonly employed management approach, with drug substitution (switching to a longer-acting medication in the same class) as the second most common strategy.17PubMed. Strategies and Management for Psychiatric Drug Withdrawal: A Systematic Review of Case Reports and Series The principle is the same whether you are tapering a person off alcohol using a benzodiazepine, switching from a short-acting benzodiazepine to a long-acting one, or slowly reducing an antipsychotic over months rather than weeks.
Who Is Most at Risk
Not everyone who stops a substance develops psychosis, even among heavy or long-term users. Several factors increase the risk. Higher doses and longer duration of use are consistently associated with more severe withdrawal across drug classes. Abrupt cessation rather than gradual tapering dramatically increases the odds. A personal or family history of psychotic illness appears to lower the threshold for developing withdrawal psychosis, particularly with cannabis and stimulants. And some withdrawal syndromes have their own specific risk factors: for dopamine agonists, it is the combination of high dose, impulse control problems during treatment, and prior brain surgery that creates the highest risk profile.16PubMed Central. Dopamine agonist withdrawal syndrome associated factors: A retrospective chart review
Age and sex appear to play a role as well. An early study of 30 consecutive cases of withdrawal psychosis found that women were overrepresented among cases following drug (non-alcohol) withdrawal, while men predominated among cases following alcohol withdrawal. The reasons for these patterns are not fully understood and likely reflect a mix of prescribing patterns, substance use patterns, and biological differences in how men and women metabolize and adapt to different substances.
Medical and psychiatric comorbidities compound the risk. Someone with liver disease may metabolize alcohol and medications more slowly, altering the withdrawal timeline. Someone with a prior traumatic brain injury or pre-existing mood disorder may have a lower threshold for psychotic symptoms. In clinical practice, withdrawal psychosis often catches people off guard because they have been taking a medication as prescribed and did not realize that stopping it could produce symptoms worse than the condition it was treating.
How Clinicians Manage and Prevent Withdrawal Psychosis
The clinical approach to drug-induced psychosis, whether from intoxication or withdrawal, involves ruling out medical emergencies, investigating the underlying cause, and then addressing the acute psychiatric symptoms. Short-term use of antipsychotic medication may be employed to manage the psychotic symptoms, with gradual discontinuation once the person is stable. Ongoing relapse prevention strategies, including both medication and non-medication approaches, are considered critical for long-term management.18PubMed. Managing drug-induced psychosis
Prevention is largely about how you stop the drug in the first place. For prescribed medications, the consensus is clear: taper slowly. How slowly depends on the drug, the dose, and the individual. Some clinicians use hyperbolic tapering schedules for antipsychotics, which involve making progressively smaller dose reductions as you approach zero, on the logic that receptor occupancy changes are proportionally largest at the lowest doses.11PubMed Central. Gradually tapering off antipsychotics: lessons for practice from case studies and neurobiological principles For substances of abuse like alcohol, supervised medical detoxification with cross-tolerant medications is the standard of care. No one should try to quit a heavy benzodiazepine or alcohol habit cold turkey without medical oversight.
Forensic and Legal Dimensions
Withdrawal psychosis raises genuinely difficult questions in legal settings. If someone commits a violent act while psychotic from drug withdrawal, how should the legal system assess their responsibility? The answer depends partly on how long the psychosis has lasted. A forensic psychiatry analysis of methamphetamine users proposed that individuals who experience persistent psychotic symptoms more than six months after stopping methamphetamine should be considered to have an independent psychotic disorder rather than a drug-induced one, which changes how their criminal responsibility is evaluated.19PubMed Central. Violent offences of methamphetamine users and dilemmas of forensic psychiatric assessment
That six-month threshold is somewhat arbitrary and remains debated, but it reflects a real clinical observation: in most cases, withdrawal psychosis resolves within days to weeks once the acute withdrawal phase passes. When it does not, clinicians start questioning whether the substance withdrawal triggered the onset of an underlying psychotic disorder that would have emerged eventually anyway, or whether prolonged substance use caused lasting brain changes that sustain psychosis independently. These distinctions are not just academic. They determine whether someone receives a psychiatric defense in court, whether they are committed for treatment, and what kind of long-term care they receive.
When Withdrawal Psychosis Gets Mistaken for Something Else
One of the most common mistakes in clinical practice is misidentifying withdrawal psychosis as a relapse of a pre-existing psychiatric condition. When someone who has been diagnosed with schizophrenia stops their antipsychotic and develops psychosis two weeks later, the reflexive clinical interpretation is that the underlying illness has broken through. But some proportion of these “relapses” are actually withdrawal effects that would resolve if the person were supported through the transition rather than immediately restarted on medication at the same or higher dose. The survey of 585 people who attempted antipsychotic withdrawal is revealing here: alongside the 18% who reported psychosis, a meaningful minority reported improved cognitive function and increased energy, suggesting that for some individuals, the medication itself was causing more harm than benefit.13Addictive Behaviors Reports. The experiences of 585 people when they tried to withdraw from antipsychotic drugs
The misidentification problem runs in the other direction too. Withdrawal psychosis from alcohol or benzodiazepines can be mistaken for a primary psychotic disorder like schizophrenia, especially if the substance use history is not well documented or the patient is unable to give a clear history during the acute episode. Alcoholic hallucinosis, with its prominent auditory hallucinations in clear consciousness, can look strikingly similar to schizophrenia. Proper diagnosis depends on getting a detailed substance use timeline and observing the course of symptoms. Withdrawal psychosis tends to resolve within days to a couple of weeks; primary psychotic disorders persist beyond that window.
For people who are navigating the discontinuation of any medication or substance and are concerned about psychotic symptoms, the practical message is straightforward. Never stop a substance abruptly if you have been using it heavily or for a long time. Work with a clinician who understands withdrawal syndromes. If psychotic symptoms do emerge, they are almost always time-limited and treatable, but they require proper medical attention. The risk of withdrawal psychosis is not a reason to avoid stopping a harmful substance. It is a reason to stop it carefully.